Sinovac Biotech Ltd. is a leading China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), Anflu(R) (influenza) and Panflu(TM)(H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine.
Reverse Merger Filing
Advanced Description :
No additional details have been entered yet. If you would like to moderate the board and provide an advanced description for this stock, please send a Board Moderation Request at top left of board.